M Ezban

Summary

Affiliation: University of Troms
Country: Norway

Publications

  1. ncbi request reprint Effects of highly purified eicosapentaenoic acid and docosahexaenoic acid on fatty acid absorption, incorporation into serum phospholipids and postprandial triglyceridemia
    J B Hansen
    Department of Medicine, Tromsø University Hospital, Norway
    Lipids 33:131-8. 1998
  2. ncbi request reprint Differential effects of low molecular weight heparin and unfractionated heparin on circulating levels of antithrombin and tissue factor pathway inhibitor (TFPI): a possible mechanism for difference in therapeutic efficacy
    J B Hansen
    Department of Medicine, Institute of Clinical Medicine, University of Tromsø, Norway
    Thromb Res 91:177-81. 1998
  3. ncbi request reprint Lipid peroxidation of isolated chylomicrons and oxidative status in plasma after intake of highly purified eicosapentaenoic or docosahexaenoic acids
    J B Hansen
    Department of Medicine, Institute of Clinical Medicine, University of Tromsø, Norway
    Lipids 33:1123-9. 1998
  4. ncbi request reprint Dietary supplementation with highly purified eicosapentaenoic acid and docosahexaenoic acid does not influence PAI-1 activity
    J Hansen
    Department of Medicine, Institute of Clinical Medicine, University of Tromso, N 9037, Tromso, Norway
    Thromb Res 98:123-32. 2000
  5. ncbi request reprint Heparin induces synthesis and secretion of tissue factor pathway inhibitor from endothelial cells in vitro
    J B Hansen
    Department of Medicine, Institute of Clinical Medicine, University of Tromsø, Norway
    Thromb Haemost 83:937-43. 2000
  6. ncbi request reprint Reduction of factor FVIIa activity during heparin therapy. Evidence for assay interactions with tissue factor pathway inhibitor and antithrombin
    J B Hansen
    Department of Medicine, Institute of Clinical Medicine, University of Tromsøo, Tromsøo, Norway
    Thromb Res 100:389-96. 2000
  7. ncbi request reprint Serum lipids and regulation of tissue factor-induced coagulation in middle-aged men
    J B Hansen
    Department of Medicine, Institute of Clinical Medicine, University of Tromsø, Tromsø, Norway
    Thromb Res 102:3-13. 2001
  8. ncbi request reprint [Antithrombotic treatment of atrial fibrillation in hospital]
    G Thomassen
    Medisinsk avdeling Regionsykehuset i Tromsø 9038 Tromsø
    Tidsskr Nor Laegeforen 121:2800-4. 2001

Collaborators

Detail Information

Publications8

  1. ncbi request reprint Effects of highly purified eicosapentaenoic acid and docosahexaenoic acid on fatty acid absorption, incorporation into serum phospholipids and postprandial triglyceridemia
    J B Hansen
    Department of Medicine, Tromsø University Hospital, Norway
    Lipids 33:131-8. 1998
    ..This study indicates that there are metabolic differences between EPA and DHA which may have implications for the use of n-3 fatty acids in preventive and clinical medicine...
  2. ncbi request reprint Differential effects of low molecular weight heparin and unfractionated heparin on circulating levels of antithrombin and tissue factor pathway inhibitor (TFPI): a possible mechanism for difference in therapeutic efficacy
    J B Hansen
    Department of Medicine, Institute of Clinical Medicine, University of Tromsø, Norway
    Thromb Res 91:177-81. 1998
    ..001). The differential effect of UFH and LMWH on antithrombin and TFPI may explain the superior efficacy of subcutaneous LMWH compared with conventional intravenous UFH for treatment of both arterial and venous thrombosis...
  3. ncbi request reprint Lipid peroxidation of isolated chylomicrons and oxidative status in plasma after intake of highly purified eicosapentaenoic or docosahexaenoic acids
    J B Hansen
    Department of Medicine, Institute of Clinical Medicine, University of Tromsø, Norway
    Lipids 33:1123-9. 1998
    ..05) and EPA supplementation increased plasma concentration of vitamin E (P < 0.05). The other lipid-soluble and polar antioxidants in plasma remained unchanged during 5 wk of intervention with highly purified n-3 FA...
  4. ncbi request reprint Dietary supplementation with highly purified eicosapentaenoic acid and docosahexaenoic acid does not influence PAI-1 activity
    J Hansen
    Department of Medicine, Institute of Clinical Medicine, University of Tromso, N 9037, Tromso, Norway
    Thromb Res 98:123-32. 2000
    ..We conclude that there is no strong evidence for an unfavourable, clinically relevant effect of n-3 fatty acids on PAI-1 activity in plasma...
  5. ncbi request reprint Heparin induces synthesis and secretion of tissue factor pathway inhibitor from endothelial cells in vitro
    J B Hansen
    Department of Medicine, Institute of Clinical Medicine, University of Tromsø, Norway
    Thromb Haemost 83:937-43. 2000
    ..It is suggested that these mechanisms are of major importance for the anticoagulant function of heparins...
  6. ncbi request reprint Reduction of factor FVIIa activity during heparin therapy. Evidence for assay interactions with tissue factor pathway inhibitor and antithrombin
    J B Hansen
    Department of Medicine, Institute of Clinical Medicine, University of Tromsøo, Tromsøo, Norway
    Thromb Res 100:389-96. 2000
    ....
  7. ncbi request reprint Serum lipids and regulation of tissue factor-induced coagulation in middle-aged men
    J B Hansen
    Department of Medicine, Institute of Clinical Medicine, University of Tromsø, Tromsø, Norway
    Thromb Res 102:3-13. 2001
    ..These findings may indicate a compensatory increase in plasma free TFPI with lipid and hemostatic risk factors for atherothrombotic diseases in healthy middle-aged men...
  8. ncbi request reprint [Antithrombotic treatment of atrial fibrillation in hospital]
    G Thomassen
    Medisinsk avdeling Regionsykehuset i Tromsø 9038 Tromsø
    Tidsskr Nor Laegeforen 121:2800-4. 2001
    ..The aim of the present study was to investigate how these recommendations are followed in clinical practice...